Wearable medical devices seen reaching $167.8 billion by 2035

The wearable medical device market is projected to grow from $50.8 billion in 2026 to $167.8 billion by 2035, driven by expanded U.S. remote-monitoring reimbursement, sensor advances and rising chronic disease. Market Research Future says the shift is turning consumer-style wearables into reimbursable clinical tools across hospitals, homes and direct-to-consumer channels.

Why it matters: - Wearable medical devices are moving from optional health gadgets to reimbursable care tools used to monitor chronic disease, manage patients at home and support hospital-at-home models. - The market’s growth is tied to long-term demand, not short-term consumer spending, which makes the category more durable through 2035. - The expansion also matters for providers and payers because continuous monitoring can shift care out of hospitals and into lower-cost settings.

What happened: - Market Research Future projects the global wearable medical device market will rise from $50.8 billion in 2026 to $167.8 billion by 2035. - The forecast implies a 14.2% compound annual growth rate from 2026 to 2035. - The market base was estimated at $44.5 billion in 2025. - The release points to U.S. CMS remote-monitoring reimbursement expansion in 2024 as a major growth driver. - The report says the 2024 code expansion unlocked an incremental $3.8 billion in annual billable services.

The details: - CMS has specific billing codes for remote patient monitoring, including 99453 for device setup, 99454 for monthly monitoring and 99457 and 99458 for treatment management. - The CMS Acute Hospital Care at Home initiative had approved 366 hospitals across 139 health systems as of early 2026. - Legislative extension of those waivers runs through September 2030. - The European Commission’s Digital Health Strategy earmarked EUR 1.3 billion for connected-diagnostics infrastructure through 2028. - The report cites Apple’s FDA-cleared ECG module, Abbott’s FreeStyle Libre continuous glucose monitor and Dexcom’s G7 platform as examples of clinical-grade wearables in consumer-style form factors. - The report says over $6.2 billion in venture and strategic investment flowed into the space during 2023–2024. - The International Diabetes Federation projects adult diabetes cases will climb from 537 million in 2021 to 783 million by 2045. - The World Health Organization identifies cardiovascular disease as the leading cause of death, with about 20 million deaths a year. - Most FDA-cleared wearables now support HL7 FHIR APIs, which enable data exchange with Epic, Cerner and MEDITECH systems. - FHIR-based integration has reduced onboarding time from months to weeks at more than 1,200 U.S. health systems. - Solid-state thin-film batteries and zinc-air micro-cells are expected to reach commercial availability by 2028, with 40% higher energy density at half the volume. - The report says wearable accelerometers with edge-AI classification are being used for fall detection, supported by specialized billing codes.

Between the lines: - The report suggests reimbursement, not just hardware innovation, is becoming the key commercial gate for wearable adoption. - Continuous monitoring is expanding the buyer base from cardiology and endocrinology specialists to primary care, home-health agencies and even consumers. - As devices become easier to integrate with electronic health records, the market may become more attractive to health systems that want workflow-ready data instead of standalone apps. - The competitive edge is shifting toward companies that can combine sensors, software, reimbursement access and clinical validation.

What’s next: - The report expects AI-driven predictive diagnostics and on-device inference to become central to wearable medical device delivery by 2030. - It says manufacturers are likely to build subscription revenue on top of device sales through coaching and risk-stratification services. - Growth is expected to continue across hospital-at-home programs, home healthcare, direct-to-consumer channels and chronic-disease management. - Regional expansion is likely to stay strongest in North America and Asia-Pacific, where reimbursement systems and digital health infrastructure are advancing fastest.

The bottom line: - Wearable medical devices are becoming a mainstream part of clinical care, and reimbursement policy is now as important as product design in determining who wins the market.